Skip to main content

Syndicate contentacute liver failure

Racial disparity studied in patients undergoing liver transplantation for hepatitis B

According to the Centers for Disease Control and Prevention (CDC) 1.5 to 2 million Americans are infected with the hepatitis B virus (HBV). Prior studies have shown there to be significant racial differences in access to and outcomes of liver transplantation. Recently, doctors from across the U.S.

Trio of signals converge to induce liver and pancreas cell development in the embryo

PHILADELPHIA - Understanding the molecular signals that guide early cells in the embryo to develop into different organs provides insight into ways that tissues regenerate and how stem cells can be used for new therapies.

International Serious Adverse Events Consortium announces initial study results in its global research collaboration to identify genetic markers related to drug induced liver injury

Chicago (June 1, 2009) ? The International Serious Adverse Events Consortium (SAEC) announced today initial results from its research designed to discover genetic markers that may predict individuals at risk for serious drug induced liver injury (DILI).

The debate over acetaminophen and acute liver failure

Acetaminophen overdose causes more than 450 deaths due to acute liver failure each year in the United States and this number appears to be on the rise. In 2001, the U.S. Acute Liver Failure (ALF) Study found acetaminophen responsible for 39 percent of cases. In 2003, the number had risen to 49 percent. William M. Lee, M.D., of the University of Texas Southwestern Medical Center in Dallas, Texas and a principal investigator of the NIH-funded U.S. Acute Liver Failure Group, suggests that the FDA should consider a more aggressive and broader approach toward regulating the pain reliever to lessen the incidence of such poisonings.

Artificial liver cuts mortality by 44%

In a major study conducted at
20 centers in the United States and Europe, a bioartificial liver reduced mortality
significantly among patients suffering from acute liver failure, the
dramatic loss of liver function that can cause death in days or even hours.
This is the first large-scale, prospective, randomized, multi-center trial
examining the effectiveness of any artificial liver support. Currently,
standard treatment consists of intensive, supportive care intended to keep
patients alive long enough that the liver might recover spontaneously or a
donor organ will become available for transplantation.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes